Skip to main content

A workshop on Human Papilloma Virus Infection and Cervical Cancer (LZP project 2021/1-0484) will be held Friday, 17 May. The agenda includes a research session with RSU researchers and an open session for patients, discussing the significance of HPV testing, screening approaches, and the role of vaccines. The research session of the event will be conducted in English, but the open session will be in Latvian.

Programme and presentations

Research session with invited RSU researchers
  • Overview of project progress during January 2022 – April 2024
    Maria Isaguliants, Institute of Microbiology and Virology, RSU, Rīga
  • Sociodemographic and general health correlates of infection with high-risk human papilloma viruses in a prospective study
    Viola Kiselova, Institute of Public Health / Institute of Microbiology and Virology, RSU, Rīga
  • Consistency of the results of liquid cytology analysis of duplicate by independent evaluators in prospective study
    Arta Spridzāne, Rīga East Clinical University Hospital / RSU, Rīga
  • Prevalence of high-risk HR HPVs in cervical dysplasia and cervical cancer, and viral correlates of disease severity in a retrospective study
    Lība Sokolovska, Institute of Microbiology and Virology, RSU, Rīga
  • Morphological features and immunohistochemical markers of HPV-associated cervical cancer
    Karina Biserova & Jurijs Nazarovs, Pauls Stradiņš Clinical University Hospital / RSU, Rīga
  • Variability of oncoprotein E6 and E7 sequences in cervical dysplasia and cervical cancer
    Juris Jansons, RSU / Biomedical Research and Study Centre, Rīga
  • Full genomic sequencing of HPV16 in cervical carcinmoas, methods to analyse genomic instability
    Valery Ilinsky, Eligens, Human Genetics, Digital Health, Rīga
Open session for patients

Cervical screening approaches, the role of screening in timely diagnosis of cervical premalignancies and cancer
Arta Spridzāne

Detection of high cancer risk papilloma viruses, how it is done, why we need to do these tests?
Beatrise Orlova, Centrālā Laboratorija, Rīga, Latvia

Study findings in the prospective cohort, positivity for high risk human papilloma viruses, cervical health and disease, treatment and perspectives for the prospective cohort
Androniks Mitiļdžans

HPV vaccination mission
Discussion (Q & A)

Location

Room
Senate Hall

Tā kā Rīgas Stradiņa universitāte ir publiska iestāde, pasākuma laikā jūs varat tikt fotografēts un/ vai filmēts. Fotogrāfijas un video var tikt publicēts universitātes mājaslapā, sociālajos medijos u. tml. Vairāk par savām tiesībām un iespēju iebilst pret šādu datu apstrādi varat uzzināt RSU Privātuma politikā. Ja iebilstat pret personas datu apstrādi, lūdzam par to informēt, rakstot uz rsuatrsu[pnkts]lv (rsu[at]rsu[dot]lv).

As Rīga Stradiņš University (RSU) is a public institution you could be photographed and/or filmed during the event. Your personal data might be used to further the interests of RSU, e.g. for marketing or communication activities (incl. social media coverage). Read more about your rights see the RSU Privacy Policy. Should you have any objections to your personal data being processed please inform us via e-mail at rsuatrsu[pnkts]lv (rsu[at]rsu[dot]lv).

Date: